Marshall Wace
MDXH icon

Marshall Wace’s MDxHealth MDXH Stock Holding History

Marshall Wace’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115K Sell
50,166
-120,465
-71% -$409K ﹤0.01% 2878
2025
Q4 		$609K Buy
170,631
+132,042
+342% +$522K ﹤0.01% 2162
2025
Q3 		$179K Buy
+38,589
New +$119K ﹤0.01% 2583

Other funds holding MDXH

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Marshall Wace's MDXH Position: Q1 2026 in Review

Marshall Wace reduced its MDxHealth (MDXH) stake by 71% in Q1 2026, selling an estimated $409K and leaving 50,166 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #2878.

Marshall Wace first reported a position in MDXH in Q3 2025 and has held it in 3 quarters since. The position peaked at $609K in Q4 2025. 51 funds tracked by Wall St. Rank hold MDXH as of Q1 2026.

  • Marshall Wace held 50,166 shares of MDxHealth worth $115K as of Q1 2026.
  • Marshall Wace sold 120,465 MDxHealth shares in Q1 2026, an estimated $409K.
  • MDxHealth made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2878 holding.
  • Marshall Wace first reported a position in MDxHealth in Q3 2025 and has held it in 3 quarters since.
  • Marshall Wace's MDxHealth position peaked at $609K in Q4 2025.
  • 51 funds tracked by Wall St. Rank held MDxHealth as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.